Kidney disease treatment is undergoing a transformation, driven by exciting new research that reveals the protective power of semaglutide in patients with type 2 diabetes. Semaglutide, a medication ...

In 2025, the FDA approved six drugs to treat various kidney diseases, including updates for Ozempic and the first approval of ...

Expert panelists share final points of emphasis regarding treatment for CKD. Ryan Haumschild, PharmD, MS, MBA: Dr Nicholas, we’ve talked a lot about halting progression. What more can we do to delay ...

Jennifer Green, MD, provides considerations for the use of SGLT2 inhibitors in treatment of CKD. Ryan Haumschild, PharmD, MS, MBA: As we talk about SGLT2s [sodium-glucose cotransporter-2 inhibitors] ...

Dapagliflozin reduced left ventricular mass index early into treatment in patients with nondialysis-dependent CKD, regardless of disease etiology and cardiovascular history. Dapagliflozin reduces left ...

New global research shows that chronic kidney disease is climbing the ranks of leading causes of death, while millions of ...

The European Renal Association (ERA) kicks off its 61st ERA Congress in Stockholm, Sweden, with a theme of "Rethinking kidney health, transforming kidney care," and a program full of sessions delving ...

Chronic kidney disease (CKD) has been called an “under-recognized public health crisis,” and is estimated to impact 14% of US adults. CKD patients typically have to undergo regular dialysis treatment ...

Editor’s note: This is an automatically generated transcript. Please notify [email protected] if there are concerns regarding accuracy of the transcription. Let's start with what causes anemia of ...

Kidney disease is the third-fastest-growing cause of death globally. Here's why doctors are sounding the alarm. Kidney disease is a serious yet often overlooked condition that affects millions ...